Judge Confirms Patent

A Federal Judge validated the patent for the drug Zyprexa on Thursday. Zyprexa is a schizophrenia drug that brought in over four million dollars in sales last year alone. The patent will make it impossible for smaller competitors to market a similar product for at least another six years. This is a great example of the United States Judicial System controlling the market. While the patent helps encourage future research, it hurts the consumers because they will probably have to pay higher prices due to the new regulations given to the drug company.